Advertisements



Takeda CEO sees path to survival in Shire takeover, Bloomberg says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Takeda clears key hurdle as investors back $59 billion Shire deal

Takeda Pharmaceutical has won shareholder approval for its $59 billion takeover of London-listed Shire , creating a global powerhouse that has a stronger drugs pipeline but is also saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

$59bln: What it costs to become a drugs player

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt. Julian Satterthwaite reports......»»

Category: videoSource: reutersDec 5th, 2018

Takeda investors back $59 billion Shire deal, but wary of debt load

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 5th, 2018

Takeda’s Shareholders Agree to $58 Billion Shire Deal Despite Debt Fears

Takeda will issue $35 billion in new stock. The long-running saga that is Takeda’s proposed takeover of Adderall maker Shire is about to enter a new chapter, with the Japanese firm’s shareholders approving the deal. On Wednesday.....»»

Category: europeSource: fortuneDec 5th, 2018

The Wall Street Journal: Takeda Pharmaceutical shareholders approve $62 billion bid for Shire

Takeda Pharmaceutical Co. won approval from shareholders Wednesday for its $62 billion bid for the U.K.’s Shire PLC, clearing the path for the biggest-ever overseas acquisition by a Japanese company......»»

Category: topSource: marketwatchDec 5th, 2018

Takeda Shareholders Approve $62 Billion Shire Bid

The approval from Takeda Pharmaceutical’s shareholders for the Shire bid clears the path for the biggest-ever overseas acquisition by a Japanese company......»»

Category: smallbizSource: wsjDec 5th, 2018

Takeda shareholders give nod for $59 billion Shire acquisition

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

Takeda shareholders approve Shire acquisition: spokesman

Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , a Takeda spokesman said, creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt......»»

Category: topSource: reutersDec 4th, 2018

EU approves Takeda buying Shire, on divestment condition

The European Commission said on Tuesday that it approved the $62-billion takeover of London's Shire plc by Takeda Pharmaceutical of Japan, subject to the divestment of a Shire drug in development......»»

Category: topSource: reutersNov 20th, 2018

Investor advisory firms back Takeda"s $62 billion deal for Shire

Two shareholder advisory firms have backed Takeda Pharmaceutical's $62 billion takeover offer for drugmaker Shire , dealing a blow to a group of investors who hope to block the deal......»»

Category: topSource: reutersNov 20th, 2018

Takeda"s Shire takeover to bring $963 million fee bonanza

Banks, law firms and other advisers stand to earn up to $963 million in fees from Takeda Pharmaceutical's $62 billion takeover of drugmaker Shire , according to documents for the deal published on Monday......»»

Category: topSource: reutersNov 12th, 2018

Takeda gets Japanese approval for Shire takeover, awaits EU nod

On Thursday, Takeda Pharmaceutical Co. Ltd. said that Japan's Fair Trade Commission has approved its $62 billion bid to acquire the second-largest biotech employer in Massachusetts, Shire Pharmaceuticals plc. According to Reuters, the deal has alre.....»»

Category: topSource: bizjournalsOct 18th, 2018

Takeda"s $62 billion Shire bid faces November 6 EU antitrust deadline

EU antitrust regulators will decide by Nov. 6 whether to allow Japanese drugmaker Takeda Pharmaceutical's $62-billion takeover of London-listed Shire Plc , the European Commission said on Friday......»»

Category: topSource: reutersSep 28th, 2018

Top Takeda investor "skeptical" about Shire takeover bid, Sunday Times reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 24th, 2018

Takeda said to mull sale of Shire eye drug to cut debt, Bloomberg reports

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 13th, 2018

Takeda weighs sale of Shire"s eye care business to cut debt: Bloomberg

Japan's Takeda Pharmaceutical is considering selling Shire Plc's eye care business once it closes its $62 billion purchase of the London-listed drugmaker, as it looks to cut the debt raised to fund the deal, Bloomberg reported on Thursday......»»

Category: topSource: reutersSep 13th, 2018

The Fed"s new interest-rate path could have the US staring at a recession by the end of next year

Bloomberg The Fed hiked rates Wednesday and said it sees two more increases this year, for a total of four. It also sees three rate hikes in 2019. The central bank .....»»

Category: topSource: businessinsiderJun 14th, 2018

Takeda global ambitions grow after Shire takeover

Takeda Pharmaceutical hopes that their $62 billion deal to purchase Shire will make them a global bio-pharmaceutical leader. But as Silvia Antonioli reports, it comes with a heavy debt burden......»»

Category: videoSource: reutersMay 9th, 2018

Takeda/Shire transaction shows path for consolidation, says Leerink

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 9th, 2018

Takeda to takeover bigger rival Shire in $62bln deal

Takeda Pharmaceutical agrees to buy London-listed Shire for 45.3 billion pounds ($61.5.....»»

Category: topSource: usatodayMay 8th, 2018